What is the current valuation of the UK dental anesthesia market?

The market valuation was $75.85 Million in 2024. Read More

What is the projected market size for the UK dental anesthesia market by 2035?

The projected valuation for 2035 is $120.84 Million. Read More

What is the expected CAGR for the UK dental anesthesia market during the forecast period 2025 - 2035?

The expected CAGR is 4.33%. Read More

Which product type generated the highest revenue in the UK dental anesthesia market?

Articaine generated the highest revenue, with a valuation range of $20.0 - $30.0 Million. Read More

What are the key players in the UK dental anesthesia market?

Key players include Dentsply Sirona, Henry Schein, and Patterson Companies. Read More

How does the revenue from local infiltration compare to other techniques?

Local infiltration generated $30.0 - $48.0 Million, outperforming other techniques. Read More

What segment is expected to have the highest revenue in the distribution channel?

Pharmacies and drug stores are expected to generate $30.0 - $48.0 Million. Read More

What is the revenue range for the mandibular mode of administration?

The revenue range for the mandibular mode is $25.0 - $40.0 Million. Read More

Which duration of action segment is projected to generate the most revenue?

The medium duration segment is projected to generate $30.0 - $50.0 Million. Read More

What is the revenue range for the end user segment of clinics?

The clinics segment is expected to generate $35.0 - $55.0 Million. Read More

UK Dental Anesthesia Market

ID: MRFR/MED/42986-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

UK Dental Anesthesia Market Research Report By Product Type (lidocaine, mepivacaine, prilocaine, bupivacaine 0.5% with epinephrine1:200,000, articaine, others), By Mode of Administration (maxillary, mandibular, others), By Technique (local infiltration, field block, nerve block), By Duration of Action (short, medium, long), By End User (hospital clinics, clinics, other), By Distribution Channel (pharmacies and drug stores, e-commerce, other) and By Intended Audience (hospitals, dental clinics, research institutes, dental software manufacturers, healthcare it companies) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Product Type (USD Million)
  1. 4.1.1 Lidocaine
  2. 4.1.2 Mepivacaine
  3. 4.1.3 Prilocaine
  4. 4.1.4 Bupivacaine 0.5% with epinephrine 1:200,000
  5. 4.1.5 Articaine
  6. 4.1.6 Others
2. 4.2 Life Sciences, BY Mode of Administration (USD Million)
  1. 4.2.1 Maxillary
  2. 4.2.2 Mandibular
  3. 4.2.3 Others
3. 4.3 Life Sciences, BY Technique (USD Million)
  1. 4.3.1 Local Infiltration
  2. 4.3.2 Field Block
  3. 4.3.3 Nerve Block
4. 4.4 Life Sciences, BY Duration of Action (USD Million)
  1. 4.4.1 Short
  2. 4.4.2 Medium
  3. 4.4.3 Long
5. 4.5 Life Sciences, BY End User (USD Million)
  1. 4.5.1 Hospital Clinics
  2. 4.5.2 Clinics
  3. 4.5.3 Other
6. 4.6 Life Sciences, BY Distribution Channel (USD Million)
  1. 4.6.1 Pharmacies And Drug Stores
  2. 4.6.2 E-Commerce
  3. 4.6.3 Other
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Dentsply Sirona (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Henry Schein (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Patterson Companies (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Septodont (FR)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Heraeus Kulzer (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 3M (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 B. Braun (DE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Kavo Kerr (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Dental Wings (CA)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY PRODUCT TYPE
3. 6.3 UK MARKET ANALYSIS BY MODE OF ADMINISTRATION
4. 6.4 UK MARKET ANALYSIS BY TECHNIQUE
5. 6.5 UK MARKET ANALYSIS BY DURATION OF ACTION
6. 6.6 UK MARKET ANALYSIS BY END USER
7. 6.7 UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL
8. 6.8 KEY BUYING CRITERIA OF LIFE SCIENCES
9. 6.9 RESEARCH PROCESS OF MRFR
10. 6.10 DRO ANALYSIS OF LIFE SCIENCES
11. 6.11 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
12. 6.12 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
13. 6.13 SUPPLY / VALUE CHAIN: LIFE SCIENCES
14. 6.14 LIFE SCIENCES, BY PRODUCT TYPE, 2024 (% SHARE)
15. 6.15 LIFE SCIENCES, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
16. 6.16 LIFE SCIENCES, BY MODE OF ADMINISTRATION, 2024 (% SHARE)
17. 6.17 LIFE SCIENCES, BY MODE OF ADMINISTRATION, 2024 TO 2035 (USD Million)
18. 6.18 LIFE SCIENCES, BY TECHNIQUE, 2024 (% SHARE)
19. 6.19 LIFE SCIENCES, BY TECHNIQUE, 2024 TO 2035 (USD Million)
20. 6.20 LIFE SCIENCES, BY DURATION OF ACTION, 2024 (% SHARE)
21. 6.21 LIFE SCIENCES, BY DURATION OF ACTION, 2024 TO 2035 (USD Million)
22. 6.22 LIFE SCIENCES, BY END USER, 2024 (% SHARE)
23. 6.23 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million)
24. 6.24 LIFE SCIENCES, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
25. 6.25 LIFE SCIENCES, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
26. 6.26 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Million)
  3. 7.2.3 BY TECHNIQUE, 2025-2035 (USD Million)
  4. 7.2.4 BY DURATION OF ACTION, 2025-2035 (USD Million)
  5. 7.2.5 BY END USER, 2025-2035 (USD Million)
  6. 7.2.6 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Life Sciences Market Segmentation

Life Sciences By Product Type (USD Million, 2025-2035)

Lidocaine
Mepivacaine
Prilocaine
Bupivacaine 0.5% with epinephrine 1:200,000
Articaine
Others

Life Sciences By Mode of Administration (USD Million, 2025-2035)

Maxillary
Mandibular
Others

Life Sciences By Technique (USD Million, 2025-2035)

Local Infiltration
Field Block
Nerve Block

Life Sciences By Duration of Action (USD Million, 2025-2035)

Short
Medium
Long

Life Sciences By End User (USD Million, 2025-2035)

Hospital Clinics
Clinics
Other

Life Sciences By Distribution Channel (USD Million, 2025-2035)

Pharmacies And Drug Stores
E-Commerce
Other

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”